178 related articles for article (PubMed ID: 25200803)
1. Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.
Corrao G; Soranna D; Arfè A; Casula M; Tragni E; Merlino L; Mancia G; Catapano AL
Eur J Intern Med; 2014 Oct; 25(8):745-50. PubMed ID: 25200803
[TBL] [Abstract][Full Text] [Related]
2. Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study.
Corrao G; Soranna D; Merlino L; Mancia G
Eur J Clin Invest; 2014 Oct; 44(10):933-9. PubMed ID: 25132063
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
[TBL] [Abstract][Full Text] [Related]
4. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
[TBL] [Abstract][Full Text] [Related]
5. Medication persistence and the use of generic and brand-name blood pressure-lowering agents.
Corrao G; Soranna D; La Vecchia C; Catapano A; Agabiti-Rosei E; Gensini G; Merlino L; Mancia G
J Hypertens; 2014 May; 32(5):1146-53; discussion 1153. PubMed ID: 24569417
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly JG; Fischer MA; Kesselheim AS; Gagne JJ
PLoS Med; 2019 Mar; 16(3):e1002763. PubMed ID: 30865626
[TBL] [Abstract][Full Text] [Related]
8. Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.
Degli Esposti L; Sangiorgi D; Buda S; Degli Esposti E; Scaglione F
BMJ Open; 2016 Nov; 6(11):e012003. PubMed ID: 27807083
[TBL] [Abstract][Full Text] [Related]
9. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
[TBL] [Abstract][Full Text] [Related]
10. When choosing statin therapy: the case for generics.
Green JB; Ross JS; Jackevicius CA; Shah ND; Krumholz HM
JAMA Intern Med; 2013 Feb; 173(3):229-32. PubMed ID: 23303273
[TBL] [Abstract][Full Text] [Related]
11. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.
Tran YB; Frial T; Miller PS
Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788
[TBL] [Abstract][Full Text] [Related]
12. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
13. Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation.
Piovani D; Clavenna A; Cartabia M; Bortolotti A; Fortino I; Merlino L; Bonati M
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):121-8. PubMed ID: 24910387
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.
Hansen RA; Qian J; Berg R; Linneman J; Seoane-Vazquez E; Dutcher SK; Raofi S; Page CD; Peissig P
Pharmacotherapy; 2017 Apr; 37(4):429-437. PubMed ID: 28152215
[TBL] [Abstract][Full Text] [Related]
15. The impact of manufacturer coupon use in the statin market.
Daugherty JB; Maciejewski ML; Farley JF
J Manag Care Pharm; 2013; 19(9):765-72. PubMed ID: 24156645
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
17. Generic versus brand-name drugs used in cardiovascular diseases.
Manzoli L; Flacco ME; Boccia S; D'Andrea E; Panic N; Marzuillo C; Siliquini R; Ricciardi W; Villari P; Ioannidis JP
Eur J Epidemiol; 2016 Apr; 31(4):351-68. PubMed ID: 26620809
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of statins reduces the risk of hospitalization for dementia.
Corrao G; Ibrahim B; Nicotra F; Zambon A; Merlino L; Pasini TS; Catapano AL; Mancia G
Atherosclerosis; 2013 Oct; 230(2):171-6. PubMed ID: 24075740
[TBL] [Abstract][Full Text] [Related]
19. Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan.
Hsu CW; Lee SY; Yang YH; Wang LJ
Int J Neuropsychopharmacol; 2020 Dec; 23(10):653-661. PubMed ID: 32598470
[TBL] [Abstract][Full Text] [Related]
20. Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series Analysis.
Leclerc J; Blais C; Rochette L; Hamel D; Guénette L; Poirier P
Am J Cardiovasc Drugs; 2019 Jun; 19(3):287-297. PubMed ID: 30471054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
